Evidence map›Paper›PMID 41551114›Full record

ArticleSAGE open medical case reports2026

Stevens-Johnson syndrome/toxic epidermal necrolysis as the initial presentation of paraneoplastic anti-TIF1-γ dermatomyositis.

Ghassan Barnawi, Raquel Lazarowitz, Lara Al-Sabeh, Ammar Saed Aldien, Ivan V Litvinov

Abstract readCase Reports
In one paragraph

Article in SAGE open medical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ghassan BarnawiDivision of Dermatology, McGill University, Montreal, QC, Canada.ORCID https://orcid.org/0009-0005-4845-5770
Raquel LazarowitzFaculty of Medicine and Health Sciences, McGill University, Montreal, QC, Canada.ORCID https://orcid.org/0009-0006-5031-6363
Lara Al-SabehFaculty of Medicine, University of Montreal, QC, Canada.
Ammar Saed AldienFaculty of Medicine and Health Sciences, McGill University, Montreal, QC, Canada.
Ivan V LitvinovDivision of Dermatology, St. Mary's Hospital Centre, Montreal, QC, Canada.ORCID https://orcid.org/0000-0003-0562-4675

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report a rare case of Stevens-Johnson syndrome/toxic epidermal necrolysis as the initial manifestation of paraneoplastic dermatomyositis in a 50-year-old man subsequently diagnosed with diffuse large B cell lymphoma, in the absence of any identifiable drug exposure. The patient presented with periorbital edema, progressive dusky blistering eruption (Nikolsky sign positive), mucositis, and histopathology consistent with Stevens-Johnson syndrome/toxic epidermal necrolysis. Over the following weeks, he developed proximal muscle weakness, elevated creatine kinase, and cutaneous signs of dermatomyositis, including heliotrope rash and Gottron's papules, with serologic confirmation via anti-TIF1-γ antibodies. Imaging revealed a hypermetabolic axillary mass, and excisional biopsy confirmed diffuse large B cell lymphoma. This case highlights a novel presentation of Stevens-Johnson syndrome/toxic epidermal necrolysis in the setting of autoimmune and paraneoplastic immune dysregulation. It underscores the importance of considering nondrug-induced triggers in Stevens-Johnson syndrome/toxic epidermal necrolysis.

Indexed as

cancerdermatomyositisDLBC-lymphomaStevens–Johnson syndrometoxic epidermal necrolysis

Identifiers

PMID41551114
PMCPMC12804626

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.